• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
The 5 Most Significant Lab Company M&A Deals of 2022

The 5 Most Significant Lab Company M&A Deals of 2022

by Glenn S. Demby | Jan 10, 2023 | News, Open Content

Merger and acquisition deal volume and value were down last year, but deal impact was not.

G2 Intelligence Launches Free Trials of Monthly Briefings

G2 Intelligence Launches Free Trials of Monthly Briefings

by Rachel Muenz | Nov 30, 2022 | Blog, News, Open Content

Readers can now gain full access to our four briefings for up to seven days for free.

FDA to Consider Health Disparities in Granting Breakthrough Device Designation

FDA to Consider Health Disparities in Granting Breakthrough Device Designation

by Glenn S. Demby | Nov 14, 2022 | News, Open Content

Medical device makers will have to show that their products will be accessible to disadvantaged populations.

Rise in Telehealth Expands Need for In-Home Phlebotomy Services

Rise in Telehealth Expands Need for In-Home Phlebotomy Services

by Glenn S. Demby | Nov 2, 2022 | News, Open Content

Mobile phlebotomist services have become a dynamic new segment of the medical labs market.

ACLA: Low Reimbursement Jeopardizes Monkeypox Lab Testing Effort

ACLA: Low Reimbursement Jeopardizes Monkeypox Lab Testing Effort

by Glenn S. Demby | Oct 19, 2022 | News, Open Content

Medicare Administrative Contractors are shortchanging labs on monkeypox test reimbursement, association says.

« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com